Efficacy and Safety of Crovalimab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Meta-Analysis
{{output}}
Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life-threatening disorder characterized by complement-mediated hemolysis. Crovalimab, a novel anti-C5 monoclonal antibody, may offer a more convenient alternative t... ...